Exacis Biotherapeutics


Exacis is developing next generation cellular therapeutics with the aim to deliver potent and targeted engineered NK and T cells to harness the human immune system and cure cancer.

We use fully proprietary mRNA based technologies to create and engineer induced pluripotent stem cells to treat liquid and solid tumors.